DIA and FDA Office of Women’s Health (OWH): Strategies for Ensuring Representation of Patient Demo

Venue: Hilton Rockville Hotel

Location: Rockville, Maryland, United States

Event Date/Time: May 05, 2010 End Date/Time: May 06, 2010
Report as Spam


Recruitment and retention issues differ for women compared to men and are likely to be unique for subgroups of women (age, ethnicity, socioeconomic factors). This conference will allow pharmaceutical companies, CROs, principal investigators, physicians, government and research institutions, and IRBs to engage in shared discussions about the recruitment and retention of women in clinical trials. Considering the multi-factorial barriers for participation of women and their retention in clinical drug trials, the conference will focus on:
— Recruitment and retention barriers for women and subgroups of women as related to age, race/ethnicity, and socio-economic factors in clinical drug trials;
— Regulatory and public health impact of under-representation of women in clinical trials
— Innovative strategies that promote improved recruitment and retention of women in clinical trials
— Current industry, CROs, principal investigators and research institutions practices to ensure adequate recruitment and retention of women in clinical trials